Printer Friendly

Beckman Coulter to Market New Reagent for Metabolic Disease Screening.

Tokyo, Japan, Mar 16, 2006 - (JCN) - Beckman Coulter recently announced that it will launch Access DHEA-S, a measuring reagent designed for its proprietary analyzers Access Immunoassay Analyzer and UniCel Dx1 800 Immunoassay System, on March 27.

Using the new reagent, analyzers are able to measure denhydroepiandrosterone sulfate (DHEA-S) in samples and deliver results in 29 minutes.

DHEA-S is a kind of steroid hormone which serves as an indicator of adrenal cancer and Cushing's syndrome, as well as metabolic diseases.

The product comes in two packages, Access DHEA-S Reagent packs (2x50 test) and calibrators (6 vials of 2mL/vial).

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Mar 16, 2006
Words:108
Previous Article:GlaxoSmithKline K.K. to Conduct Clinical Study of HPV Vaccine.
Next Article:Hitachi, Bridgestone to Join Hands in Electronic Paper Display Business.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters